DG-013-A

N/A

Report date: 2024/08/05 17:53:44
NME

Base Information

Drug NameDG-013-A
Drug Alias NameDG-013-A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesCancer Research UKSuzhou Degen Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A